inSomaBio

Durham, United States

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.

$1.9M raised

Oct 2025

Seed

Top Investors

National Science FoundationY CombinatorAsymmetry VenturesNorth Carolina Biotechnology CenterCAV Angels

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has inSomaBio raised?

inSomaBio has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are inSomaBio's investors?

inSomaBio's investors include National Science Foundation, Y Combinator, Asymmetry Ventures, North Carolina Biotechnology Center, CAV Angels.

Where is inSomaBio headquartered?

inSomaBio is headquartered in Durham, United States.

What does inSomaBio do?

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.

What stage is inSomaBio at?

inSomaBio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 20, 2025.

MLA

"inSomaBio — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/insomabio. Accessed June 4, 2026.

APA

VCBacked. (2025). inSomaBio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/insomabio

Wikipedia (cite web)

{{cite web |title=inSomaBio — Funding & Investors |url=https://www.vcbacked.co/company/insomabio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 20, 2025.